Real-world Application of the Chicago Classification Version 4.0 for Esophageal Manometry: Asian Multicenter Study

芝加哥分类法4.0版在食管测压中的实际应用:亚洲多中心研究

阅读:1

Abstract

BACKGROUND/AIMS: The Chicago classification version 4.0 (CC v4.0) proposes a standardized high-resolution manometry protocol for more sophisticated diagnosis of esophageal motility disorders. We aim to investigate the real-world application of CC v4.0 through multi-institutional surveys in Asian countries. METHODS: We requested a total of 161 questionnaires from members of the Asian Neurogastroenterology and Motility Association via Google Survey from March to June 2023. The questionnaire assessed CC v4.0 protocol compliance and diagnosis. RESULTS: Responses were received from 33 centers in 9 countries (18 in Korea, 5 in Japan, and 10 in others). Among these, anticholinergics were investigated in 14 centers (42.4%), and narcotic drugs in 16 centers (48.5%). Eight centers (24.2%) fully adhered to CC v4.0 protocol for single wet swallows and provocation tests. Nine centers (27.3%) had an adaptation period < 60 seconds, 13 centers (39.4%) had < 3 breath counts, and 15 centers (45.5%) had swallowing intervals < 30 seconds (42.4% had 10-29 seconds and 3% had < 10 seconds). Twenty-four centers (72.7%) started the examination in a supine position and 13 centers (39.4%) did not change their position. Among 27 centers (81.8%) applying provocation tests, all applied multiple rapid swallows, whereas rapid drink challenge was applied in 19 (57.6%). Timed barium esophagography and functional lumen imaging probe were available in 16 (48.5%) and 6 centers (18.2%), respectively. CONCLUSIONS: We observed heterogeneity among centers in the application of CC v4.0 protocol. To increase inter-center reliability and minimize diagnostic ambiguity, efforts should continue toward the practical clinical application of standard protocols.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。